| 英文名稱(chēng) |
中文名稱(chēng) |
CAS號(hào) |
操作 |
| 2,6-Dichloro-4-pyridinol |
2,6-二氯-4-吡啶醇 |
17228-74-9 |
詳細(xì)
|
| Cholesterol Impurity 44 (7-Dehydrodesmosterol) |
膽固醇雜質(zhì)44（7-脫氫橋甾醇） |
1715-86-2 |
詳細(xì)
|
| Atropine Impurity 21 |
阿托品雜質(zhì)21 |
17126-67-9 |
詳細(xì)
|
| DOTA-NHS-ester |
1,4,7,10-四氮雜環(huán)十二烷-1,4,7,10-四乙酸 1-(2,5-二氧代-1-吡咯烷基)酯 |
170908-81-3 |
詳細(xì)
|
| Sitagliptin Impurity 97 |
西他列汀雜質(zhì)97 |
1675201-13-4 |
詳細(xì)
|
| Lurasidone Impurity 95 |
魯拉西酮雜質(zhì)95 |
1687-30-5 |
詳細(xì)
|
| Indacaterol Impurity 79 |
茚達(dá)特羅雜質(zhì)56 |
172967-64-5 |
詳細(xì)
|
| Benzenesulfonic Acid Impurity 22 |
苯磺酸雜質(zhì)22 |
172973-70-5 |
詳細(xì)
|
| Fasudil Hydrochloride Impurity A |
鹽酸法舒地爾雜質(zhì)A |
|
詳細(xì)
|
| Cariprazine Impurity 16 |
卡利拉嗪雜質(zhì)16 |
1698050-40-6 |
詳細(xì)
|
| tribenzyl phosphate |
磷酸三芐基 |
1707-92-2 |
詳細(xì)
|
| Fexofenadine Impurity 28 |
非索非那定雜質(zhì)28 |
169032-11-5 |
詳細(xì)
|
| Evocalcet Impurity 8 |
伊萬(wàn)卡賽雜質(zhì)8 |
1666124-30-6 |
詳細(xì)
|
| Sunitinib Impurity 64 |
舒尼替尼雜質(zhì)64 |
17120-26-2 |
詳細(xì)
|
| Voriconazole Impurity 48 |
伏立康唑雜質(zhì)48 |
1702684-04-5 |
詳細(xì)
|
| Naproxen Impurity 45 |
萘普生雜質(zhì)45 |
17295-11-3 |
詳細(xì)
|
| Dapagliflozin Impurity 168 |
達(dá)格列凈雜質(zhì)168 |
1713015-63-4 |
詳細(xì)
|
| 1,1,1,3-Tetrachloroacetone |
1,1,1.3-四氯丙酮 |
16995-35-0 |
詳細(xì)
|
| DL-Alanine, phenyl ester |
DL-丙氨酸，苯基酯 |
167088-01-9 |
詳細(xì)
|
| Ezetimibe Impurity 128 |
依澤替米貝雜質(zhì)128 |
1689-73-2 |
詳細(xì)
|
| Doxapram hydrochloride EP Impurity B |
鹽酸多沙普侖EP雜質(zhì)B |
1688-76-2 |
詳細(xì)
|
| PD-1/PD-L1 inhibitor 2 (BMS-202) |
PD-1/PD-L1抑制劑雜質(zhì)2(BMS-202) |
1675203-84-5 |
詳細(xì)
|
| Tedizolidted Impurity X |
泰地唑胺雜質(zhì)X |
171018-17-0 |
詳細(xì)
|
| Crisaborole Impurity 95 |
克立硼羅雜質(zhì)95 |
171364-82-2 |
詳細(xì)
|
| Aprepitant Impurity 58 |
阿瑞匹坦雜質(zhì)58 |
172678-47-6 |
詳細(xì)
|
| (E)-1-(benzylideneamino)indoline-2,3-dione |
（E）-1-（亞芐基氨基）吲哚-2,3-二酮 |
1669422-54-1 |
詳細(xì)
|
| Sarpogrelate Impurity 9 |
沙格雷酯雜質(zhì)9 |
167145-13-3 |
詳細(xì)
|
| PD-1/PD-L1 inhibitor Impurity 8 (BMS 1) |
PD-1/PD-L1抑制劑雜質(zhì)8(BMS 1) |
1675201-83-8 |
詳細(xì)
|
| 1-(2-ethylphenyl)propan-1-one |
1-（2-乙基苯基）丙烷-1-酮 |
16819-79-7 |
詳細(xì)
|
| Ethyldiphenylphosphine oxide |
乙基二苯基氧化膦 |
1733-57-9 |
詳細(xì)
|
| Gadobutrol Impurity 43 |
釓布醇雜質(zhì)116 |
16695-22-0 |
詳細(xì)
|
| Ilaprazole Impurity 81 |
艾普拉唑雜質(zhì)81 |
172152-60-2 |
詳細(xì)
|
| Pregabalin Impurity 117 |
普瑞巴林雜質(zhì)117 |
1696397-15-5 |
詳細(xì)
|
| Saxagliptin Impurity 44 |
沙格列汀雜質(zhì)44 |
1714126-77-8 |
詳細(xì)
|
| Sotalol hydrochloride EP Impurity A |
鹽酸索他洛爾EP雜質(zhì)A |
16974-42-8 |
詳細(xì)
|
| Acrivastine D7 |
阿曲司汀D7 |
172165-56-9 |
詳細(xì)
|
| Bromoxynil |
溴苯腈 |
1689-84-5 |
詳細(xì)
|
| Cefazolin EP Impurity I (Usp Impurity L,Cefazoloic Acid Isomers) |
頭孢唑啉雜質(zhì)35 |
1675244-99-1 |
詳細(xì)
|
| Articaine EP Impurity A |
阿替卡因EP雜質(zhì)A |
1712677-79-6 |
詳細(xì)
|
| 1,3,6,9-tetraoxa-2-thiacycloundecane 2,2-dioxide |
1,3,6,9-四氧-2-硫環(huán)十一烷2,2-二氧化物 |
1680182-60-8 |
詳細(xì)
|
| Bisphenol A Diglycidyl Ether |
雙酚A二縮水甘油醚 |
1675-54-3 |
詳細(xì)
|
| (S)-tetrahydrofuran-3-yl formate |
（S）-甲酸四氫呋喃-3-基酯 |
167979-56-8 |
詳細(xì)
|
| 1,3-dihydroxypropan-2-yl dodecanoate |
1,3-二羥基丙-2-基十二烷酸酯 |
1678-45-1 |
詳細(xì)
|
| Ipamorelin |
伊帕瑞林 |
170851-70-4 |
詳細(xì)
|
| Cyproterone acetate EP Impurity C |
醋酸環(huán)丙孕酮EP雜質(zhì)C |
17183-98-1 |
詳細(xì)
|
| Gadobutrol Impurity 97 |
釓布醇雜質(zhì)97 |
173308-19-5 |
詳細(xì)
|
| Idarubicin Impurity 3 |
依達(dá)比星雜質(zhì)3 |
16883-16-2 |
詳細(xì)
|
| Aprepitant Impurity 63 |
阿瑞吡坦雜質(zhì)63 |
172676-88-9 |
詳細(xì)
|
| Nirmatrelvir Impurity 57 |
奈瑪特韋雜質(zhì)57 |
169870-82-0 |
詳細(xì)
|
| Moxifloxacin Impurity 173 |
莫西沙星雜質(zhì)173 |
169507-61-3 |
詳細(xì)
|
| 3-methylisoxazole-4-carboxylic acid |
3-甲基異惡唑-4-羧酸 |
17153-20-7 |
詳細(xì)
|
| Desmopressin |
去氨加壓素 |
16679-58-6 |
詳細(xì)
|
| Glutamic Acid Impurity 4 |
谷氨酸雜質(zhì)4 |
16874-06-9 |
詳細(xì)
|
| Erdosteine Impurity 5 |
厄多司坦雜質(zhì)5 |
1667709-77-4 |
詳細(xì)
|
| 1,1'-biphenyl]-4-yl diphenyl phosphate |
1,1’-聯(lián)苯]-4-二苯基磷酸酯 |
17269-99-7 |
詳細(xì)
|
| Brexpiprazole Impurity 116 |
依匹哌唑雜質(zhì)116 |
1677681-04-7 |
詳細(xì)
|
| Vortioxetine Impurity 33 |
沃替西汀雜質(zhì)33 |
16704-47-5 |
詳細(xì)
|
| C-Veratroylglycol |
C-藜蘆酰乙二醇 |
168293-10-5 |
詳細(xì)
|
| Relugolix Impurity 77 |
瑞盧戈利雜質(zhì)77 |
1703-10-2 |
詳細(xì)
|
| Entacapone Impurity 89 |
恩他卡朋雜質(zhì)89 |
17028-61-4 |
詳細(xì)
|
| Linaclotide Impurity 24 |
利那洛肽雜質(zhì)24 |
16966-09-9 |
詳細(xì)
|
| Lidocaine Impurity 36 |
利多卡因雜質(zhì)36 |
16947-63-0 |
詳細(xì)
|
| Revefenacin Impurity 71 |
雷芬那辛雜質(zhì)46 |
171723-80-1 |
詳細(xì)
|
| Benidipine Impurity P |
苯那地平雜質(zhì)P |
166808-97-5 |
詳細(xì)
|
| 3-nitropyridin-4-amine |
3-硝基吡啶-4-胺 |
1681-37-4 |
詳細(xì)
|
| Diafenthiuron Impurity 1 |
丁醚脲雜質(zhì)1 |
169337-81-9 |
詳細(xì)
|
| Vitamin K1 Impurity 141 |
維生素K1雜質(zhì)141 |
16825-16-4 |
詳細(xì)
|
| Biotin Impurity 12 |
生物素雜質(zhì)12 |
171232-73-8 |
詳細(xì)
|
| Levosimendan Impurity 78 |
左西孟旦雜質(zhì)78 |
16960-49-9 |
詳細(xì)
|
| Deferiprone Impurity 2 |
去鐵酮雜質(zhì)2 |
17184-19-9 |
詳細(xì)
|
| Tedizolid Phosphate Impurity L |
泰地唑胺雜質(zhì)L |
1700656-53-6 |
詳細(xì)
|
| Lornoxicam Impurity 55 |
氯諾昔康雜質(zhì)55 |
167023-62-3 |
詳細(xì)
|
| Safinamide Impurity 10 |
沙芬酰胺雜質(zhì)10 |
172685-67-5 |
詳細(xì)
|
| Fluralaner Impurity 42 |
氟雷拉納雜質(zhì)42 |
170230-01-0 |
詳細(xì)
|
| 6-hydroxy-2-naphthoic acid |
6-羥基-2-萘甲酸 |
16712-64-4 |
詳細(xì)
|
| Antipyrine Impurity 3 |
安替比林雜質(zhì)3 |
1672-59-9 |
詳細(xì)
|
| Apremilast Impurity 127 |
阿普斯特雜質(zhì)127 |
17011-53-9 |
詳細(xì)
|
| Nebivolol Impurity 33 |
奈比洛爾雜質(zhì)33 |
1696472-15-7 |
詳細(xì)
|
| Ilaprazole Impurity 33 |
艾普拉唑雜質(zhì)33 |
172152-43-1 |
詳細(xì)
|
| Ursodeoxycholic Acid Impurity 52 |
熊去氧膽酸雜質(zhì)52 |
168417-80-9 |
詳細(xì)
|
| Arsenazo-III |
偶氮胂-III |
1668-00-4 |
詳細(xì)
|
| Butalbital Impurity 1 |
布他比妥雜質(zhì)1 |
17048-97-4 |
詳細(xì)
|
| Calcitriol Impurity 43 |
骨化三醇雜質(zhì)43 |
169900-32-7 |
詳細(xì)
|
| Lornoxicam Impurity 47 |
氯諾昔康雜質(zhì)47 |
16817-89-3 |
詳細(xì)
|
| Zanubrutinib |
澤布替尼 |
1691249-45-2 |
詳細(xì)
|
| Sildenafil citrate |
枸櫞酸西地那非 |
171599-83-0 |
詳細(xì)
|
| Paclitaxel Impurity 66 |
紫杉醇雜質(zhì)66 |
173101-47-8 |
詳細(xì)
|
| Isosorbide Impurity 24(Isomannide 2-Nitrate) |
異山梨酯雜質(zhì)24（2-硝酸異甘露醇） |
16908-90-0 |
詳細(xì)
|
| Glycopyrronium Bromide Impurity 13 |
格隆溴銨雜質(zhì)13 |
173277-80-0 |
詳細(xì)
|
| 1,3,3-trichloro-4-methylpentan-2-one |
1,3,3-三氯-4-甲基戊烷-2-酮 |
171818-11-4 |
詳細(xì)
|
| Brexpiprazole Impurity 117 |
依匹哌唑雜質(zhì)117 |
1700655-62-4 |
詳細(xì)
|
| 4-methyldihydrofuran-2(3H)-one |
4-甲基二氫呋喃-2（3H）-酮 |
1679-49-8 |
詳細(xì)
|
| Nicardipine Impurity 51 |
尼卡地平雜質(zhì)51 |
167963-66-8 |
詳細(xì)
|
| EtoposideInjection Impurity 6 |
依托泊苷注射液雜質(zhì)6 |
172138-89-5 |
詳細(xì)
|
| Fexofenadine Impurity 32 |
非索非那定雜質(zhì)32 |
169280-25-5 |
詳細(xì)
|
| Adenosine Impurity 45 |
腺苷雜質(zhì)45 |
16667-73-5 |
詳細(xì)
|
| (2-hydroxyethoxy)methyl acetate |
（2-羥基乙氧基）乙酸甲酯 |
170159-11-2 |
詳細(xì)
|
| Naproxen Impurity 51 |
萘普生雜質(zhì)51 |
17295-12-4 |
詳細(xì)
|
| Cucurbitacin Impurity 11 |
葫蘆素雜質(zhì)11 |
17278-28-3 |
詳細(xì)
|
| Caspofungin Impurity 6 |
卡泊芬凈雜質(zhì)6 |
1671884-42-6 |
詳細(xì)
|